D2B3
PrivateLast Round
Pre Seed
Jun 1, 2024
Total Funding Raised
$500,000
Company Overview
D2B3 is a biotechnology company that operates a pre-clinical platform intended to advance drug delivery to the brain and central nervous system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
D2B3 Comparables
Compare D2B3 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qinotto, Inc. | 83% | |
| Gate2Brain | 82% | |
| Sylamore Bio | 76% |
D2B3 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jun 1, 2024 |
D2B3 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Pre Seed |
| Alexandria LaunchLabs | Pre Seed |
| Yale Ventures | Pre Seed |
| Mission BioCapital | Pre Seed |
| SOSV | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2024
$500K round led by Mission BioCapital.
D2B3 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about D2B3's valuation, stock price, and market status.
Is D2B3 a public or private company?
D2B3 is a private company.
What is the current stock price of D2B3?
D2B3 is a private company with no public stock price. No recent secondary market data is available.
How much is D2B3 worth (valuation)?
Valuation information for D2B3 is not publicly available.
Can I buy D2B3 stock?
D2B3 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was D2B3's last funding round?
D2B3's most recent funding round was Pre Seed on June 1, 2024.
Who are the main investors in D2B3?
Key investors in D2B3 include Mission BioCapital.
Will D2B3 IPO soon?
No public IPO plans have been announced for D2B3.
How can I track D2B3 secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor D2B3's secondary market activity and sign up for updates.